Arkolith/Insider Trading/RGRX/Form 4

Cavazza Preta Martina

10% OwnerREGENERX BIOPHARMACEUTICALS INC (RGRX) · full profile →Form 4 · filed Jul 6, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
0 non-derivative · 2 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 3, 2023Other(J)0———
Jul 3, 2023Buy(P)3.8M$50000.00$187.5B3.8M

Transaction Codes

J
Other acquisition / disposition
P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-23-055186) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML